Calithera Biosciences, Inc.
CALADelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496671
Calithera Biosciences, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on May 26, 2023; 29 institutions reported holding it in 13F filings for Q2 2022, worth $4.44M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Calithera Biosciences, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 2 | −21 |
| Shares | 1.54M | 1.20K | −1.53M (−99.9%) |
| Value | $5.01M | $3.92K | −$5.00M (−99.9%) |
New holders (0)
Institutions that held Calithera Biosciences, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
None.
Sold out (21)
Institutions that held Calithera Biosciences, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| BVF Inc | 464,742 | $1.52M |
| Primecap Management Co | 401,080 | $1.31M |
| Citadel Advisors LLC | 199,269 | $649.6K |
| Acadian Asset Management LLC | 155,070 | $505.0K |
| BlackRock Inc. | 83,839 | $273.3K |
| Renaissance Technologies LLC | 66,795 | $218.0K |
| Vanguard Group Inc | 47,169 | $153.8K |
| TSP Capital Management Group, LLC | 44,750 | $145.9K |
| Geode Capital Management, LLC | 29,176 | $95.0K |
| JPMorgan Chase & Co | 24,345 | $79.0K |
| State Street Corp | 10,805 | $35.2K |
| Wells Fargo & Company | 3,782 | $12.3K |
| Morgan Stanley | 697 | $2.27K |
| Coppell Advisory Solutions LLC | 675 | $2.20K |
| Coppell Advisory Solutions Corp. | 675 | $2.20K |
| Group One Trading, L.P. | 660 | $2.15K |
| Bank of America Corp | 539 | $1.76K |
| UBS Group AG | 321 | $1.05K |
| Arcus Capital Partners, LLC | 250 | $815 |
| Truvestments Capital LLC | 52 | $170 |
| Citigroup Inc | 14 | $46 |